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Hev b 6.02 Is the Most Important
Allergen in Health Care Workers
Sensitized Occupationally by Natural
Rubber Latex Gloves
Akiko Yagami1,2, Kayoko Suzuki2, Hirohisa Saito1 and Kayoko Matsunaga2
ABSTRACT
Background: Natural rubber latex (NRL) allergy is a common occupational disease in health care workers
(HCW). However, few reports have compared the major allergen of HCWs to those in gloves that are routinely
used in the hospital. The aim of this study was to evaluate the major NRL allergens in gloves used by HCWs.
Methods: We studied 20 HCWs who were suspected to have latex allergy (LA). We performed a skin prick
test (SPT) using NRL allergens. Serological testing was performed using the ImmunoCAPTM. The total amount
of protein and the antigenic protein concentrations extracted from NRL gloves were measured. Four different
types of FITkitTM were used to measure the concentrations of Hev b 1, 3, 5, and 6.02 in the gloves.
Results: A SPT using NRL extract identified 14 cases with positive reactions. The sensitivity and specificity of
the SPT scores to the NRL glove extract were 100%. The sensitivity of latex specific IgE was 100% but the
specificity was 14.2%. The sensitivity and specificity of rHev b 6.02 specific IgE were 100% in the LA group.
The total amounts of protein from the medical gloves for surgery and examination were 265 μgg and 95 μgg,
respectively. The antigenic protein concentrations in the gloves were 24.9 μgg and 1.0 μgg, respectively. The
total amounts of the specific four allergens in the NRL gloves were 2.18 μgg and 0.45 μgg, respectively.
Conclusions: We concluded that the main allergen of HCWs who have been sensitized occupationally by
NRL gloves was Hev b 6.02.
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INTRODUCTION
Type I allergy to natural rubber latex (NRL) in health
care workers (HCWs) is a well-known problem. Be-
tween 3% and 17% of HCWs have become sensitized
to NRL.1-3 In February 2006, the WHOIUIS Allergen
Nomenclature Committee (www.allergens.org) listed
13 NRL Hev b allergens as molecularly characterized
proteins.4-13 Among children with latex allergy (LA),
who is often associated with spina bifida (SB), hydro-
phobic proteins bound to rubber particles, such as
Hev b 1 (rubber elongation factor) and Hev b 3 (small
rubber particle protein), have been reported to be
very important allergens.4,14 On the other hand, in
HCWs with LA, hydrophilic proteins, such as Hev b 5
(acidic latex protein) and Hev b 6.02 (hevein), have
been reported to be important allergens.7,15 Such dif-
ferences are attributed to different routes of allergen
exposure and different amounts of major allergic pro-
teins eluted from the causable products in these pa-
tient groups. In most children with LA, sensitization
and induction of LA may occur by direct contact of
the internal mucosa with NRL products during sur-
gery to treat SB or congenital disorders, which is re-
peated many times after birth, or catheterization for
the maintenance of excretion routes.14,15 On the
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other hand, in HCWs with LA, sensitization and in-
duction of LA may mainly occur by skin contact, such
as wearing NRL gloves or by inhaling latex aeroaller-
gens, such as allergic protein-adsorbed powder.16-18
No studies have examined the amount of allergic pro-
teins eluted from commercially available NRL prod-
ucts in Japan. The aims of this study were to charac-
terize the major allergens in HCWs occupationally
sensitized to latex in and to clarify the difference with
the LA observed in children often complicated by SB.
METHODS
SUBJECTS
We studied 20 HCWs at the Fujita Health University
Hospital (Aichi, Japan) in the 1990s who were sus-
pected to have LA. These workers had used the same
types of surgical and examination NRL gloves. We
performed the skin prick test (SPT) using NRL glove
extract, and used these test results to divide the
HCWs into allergen-positive and -negative groups
(LA group and non-LA group, respectively). The
study group consisted of three males and 17 females
(mean age, 29.3 years; range, 23―46 years). With re-
gard to the clinical symptoms of LA, three patients
had anaphylaxis, three had respiratory symptoms and
urticaria, three had generalized urticaria and five had
contact urticaria. The LA clinical symptoms ranged
from minor indications such as contact urticaria, eye
symptoms, facial edema, generalized urticaria, rhini-
tis, and asthma, to more severe symptoms such as
anaphylactic shock. We classified the degree of
symptoms into four groups, Stages 1―4, according to
the classification of the contact urticaria syndrome
described by Krough and Maibach.19 The stage de-
scriptions were as follows: Stage 1, localized urticaria,
dermatitis, nonspecific symptoms, itching, tingling,
burning, etc.; Stage 2, general urticaria and extracuta-
neous reactions; Stage 3, bronchial asthma, rhino
conjunctivitis, pharyngeal larynx symptoms, and gas-
trointestinal symptoms; and Stage 4, anaphylactic
shock. In the LA group, three patients were Stage 4,
three were Stage 3, three were Stage 2, and five were
Stage 1 (Fig. 1, Table 1, 2). At the time of diagnosis,
five subjects worked as nurses in the intensive care
unit or the operating room, nine worked as nurses in
the general ward, two were medical technicians, two
were nursing assistants in the general ward, and two
were doctors. Twelve out of the 20 subjects (60.0%)
had complications from other allergic diseases such
as atopic dermatitis (AD), allergic rhinitis (AR), aller-
gic conjunctivitis (AC), and bronchial asthma (BA).
Three subjects had AD, AR, and BA, two had AD and
AR, four had only AD, three had only AR, and one
had BA. HCWs were diagnosed with NRL sensitiza-
tion based on positive SPT results with NRL glove ex-
tract or a positive NRL glove use test and clinical
symptoms compatible with NRL glove use.
SKIN TEST
SPT
We made extracts from NRL gloves that HCWs had
used in the 1990s following the method of Turjanmaa
et al.20 and purchased recombinant (r) allergens
(rHev b 1, 3, 5, 6.02, 8, 9, and 11) from BIOMAY, Vi-
enna, Austria. The allergens were diluted to 100 μg
ml in distilled water. As for quality control, all materi-
als were stored at −20℃ to avoid repeat freezing
thawing.
One drop of the diluted solution was applied to the
skin on the forearm, which was then pierced with a
lancet (PRICK-LANCETTER, Ewo Care AB, Swe-
den).20,21 The drops were removed with a paper
towel, and the test was evaluated 15 minutes later. A
wheal at least half the size of that caused by hista-
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Table 2 List of 6 cases without latex alergy
rHev b6.02 
specific IgE 
(UA/ml)　
Latex 
specific IgE 
(UA/ml)
NRL glove 
use test
rHev b6.02 
skin prick 
test score
Latex skin 
prick test 
score
IgE RIST
 (IU/ml)
Personal 
alergic 
history
OccupationAgeSexCase No
＜0.350.77negativeNDnegative1020AD, ARNs of general 
ward       
23F1
＜0.350negativeNDnegative  87.8ARNs of general 
ward
23F2
＜0.353.01negativeNDnegative 250AD, ARNs of general 
ward
23M3
＜0.352.01negativeNDnegative 135ARMedical 
assistant
38F4
＜0.351.51negativeNDnegative  78(－)Ns of general 
ward
32F5
＜0.354.22negativeNDnegative1100(－)Radiologist 43M6
ND, Not done.
(n 㧩 14)
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20
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80
100
Latex
extract
rHev b1 rHev b3 rHev b5 rHev
b6.02
rHev b8 rHev b9 rHev
b11
Fig. 2 Prevalence percent of LA group exhibiting positive SPT responses 
to Hevea brasiliensis proteins.
mine dihydrochloride (10 mgml) was considered a
positive reaction. PS was used as a negative control,
and the scores were assigned as follows: 2+, between
half to the same size (as that caused by histamine);
3+, the same size; and 4+, a larger size. Scores of 2+
or greater were considered positive.
NRL Glove Use Test
The subject who showed a negative reaction in SPTs
wore a NRL glove on one finger, which was wetted
with water, and a control chloroprene glove on the
opposite finger for 15 minutes.20,21 If subjects showed
no symptoms, they wore the NRL glove on the whole
hand and the chloroprene glove on the opposite
hand.
IMMUNOGLOBULIN E ANTIBODY ANALYSES
Serological testing was performed using the Immuno-
CAPTM system (Phadia, Uppsala, Sweden). All sera
were analyzed for latex specific IgE. The LA group
was analyzed with rHev b 1, 3, 5, 6.01, 6.02, 8, 9, and
11.
The values obtained ranged from Classes 1 to 6.
IgE levels more than 0.70 IUml (Class 2) were con-
sidered positive.
GLOVE ANALYSIS
Glove Collection
The Fujita Health University provided two brands of
medical gloves for surgery and examinations used in
the 1990s. The surgical glove was a powdered one
(Micro-Touch Surgical Gloves, Johnson & Johnson,
NJ, USA), and the examination glove was a non pow-
dered one (Glovex Eco Latex Exam Gloves, Termo
Beiersdorf, Tokyo, Japan).
Extraction of Latex Allergens
The NRL gloves were cut into small pieces which
were mixed carefully. Subsequently, 1 g of the mix-
ture was weighed and extracted in 5 ml of phosphate-
buffered saline, pH 7.2.
Measurements of Total Amounts of Proteins and
Allergens
The total amount of protein in each extract was meas-
ured by the ASTM D5712-95 method (modified
Lowry method), and the antigenic protein concentra-
Hev b 6.02 Is the Most Important Allergen in Health Care Workers
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Fig. 3 The corelation of the severity and SPT scores of NRL glove extract in 
LA group.
1 2 3 4
1
2
3
4
Severity
SPT score (NRL glove extract)
(score)
(stage)
r 㧩 0.6156123
P 㧨 0.01
Fig. 4 The corelation of the severity and SPT scores of rHev b 6.02 in LA 
group.
1 2 3 4
1
2
3
4
Severity
SPT score (rHev b6.02) 
(score)
(stage)
r 㧩 0.7245145
P 㧨 0.01
tion was measured by the ASTM D6499-00 method
(ELISA inhibition assay).22
Quantification of Individual Allergens
Four different allergens with FITkitTM (FIT Biotech
Ltd, Tampere, Finland) were used to measure the
concentrations of Hev b 1, Hev b 3, Hev b 5 and Hev
b 6.02 in the NRL glove extracts.23 The detection lim-
its of FITkitTM for allergens are as follows: Hev b 1,
50 ngg; Hev b 3, 50 ngg; Hev b 5, 25 ngg; Hev b
6.02, 25 ngg. Values below these detection limits
were denoted as zero. The sum of the four allergens
in the NRL glove extracts was denoted as the aller-
gen sum (μgg).
STATISTICS
Fisher’s exact test was performed to examine the sen-
sitivity and specificity of the SPT score and serum
specific IgE analysis.
The correlation between individual SPT scores or
the serum IgE antibody levels and the severities of
the LA group was assessed by a non-parametric
Spearman’s r-test.
ETHICAL CONSIDERATION
We obtained informed consent from each subject to
perform the examination and to publish the final re-
sults.
RESULTS
First, we performed a SPT on 20 subjects using NRL
extract and identified 14 cases with positive reactions
and six cases with negative reactions. Then, we per-
formed a SPT using recombinant allergens in the 14
cases that reacted positively to the NRL extract.
Yagami A et al.
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Table 3 Alergen levels of diferent brands of NRL gloves
Hev b 6.02
(μg/g)
Hev b 5
(μg/g)
Hev b 3
(μg/g)
Hev b 1
(μg/g)
Antigenic 
protein
concentration
(μg/g)
Total 
amount of 
proteins
(μg/g)
Powderd 
or Non 
powdered
Manu-
facturing 
time
Type of glove
2.150.03NDND24.9265Powderd1996Micro-Touch 
Surgical Gloves
Johnson
&
Johnson
0.230.22NDND 1.0 95Non 
powdered
1998Glovex Eco
Latex Exam
Gloves
Termo
Beiersdorf
ND, not detected.
Fig. 5 Prevalence percent of LA group exhibiting positive 
specific IgE responses to Hevea brasiliensis proteins.
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In the SPT-negative subjects, we performed the
glove use test.
SKIN TEST RESULTS
SPT Results
The sensitivity and specificity of the SPT scores to
the NRL glove extract were 100%. The positive ratios
of SPT for latex extract and rHev b 6.02 in the LA
group were 100%, while those for rHev b 5, rHev b 8,
and rHev b 9 were 21.4 %, 13.3 %, and 7.1 %, respec-
tively. rHev b 1, 3, and 11 were all negative in the LA
group (Fig. 2). There were significant correlations be-
tween the severity stage and the SPT scores for the
NRL glove extract or rHev b 6.02 in the LA group
(Spearman’s rank correlation coefficient; r = 0.615;
P < 0.01 and r = 0.724; P < 0.01, respectively) (Fig. 3,
4).
Glove Use Test Results
We performed a glove use test in the six cases with a
negative SPT reaction to NRL gloves. All of them re-
acted negatively in the use test (Fig. 1, Table 2).
SERUM SPECIFIC IgE RESULTS
The sensitivity of latex specific IgE was 100%,
whereas the specificity was 14.2%. The latex specific
IgEs were not significantly different in the LA group
compared to the non-LA group (Table 1, 2). The posi-
tive ratios of serum specific IgE for latex, rHev b 6.01,
and 6.02 in the LA group were 100%, while those for
rHev b 5, rHev b 8, and rHev b 11 were 42.8%, 14.2%,
and 7.1%, respectively (Fig. 5). rHev b 6.02 specific
IgE had the highest frequency of positive reaction in
comparison with the other allergen proteins in
HCWs.
There were no significant correlations between the
severity stages and serum specific IgEs against latex
or rHev b 6.02 in the LA group.
GLOVE ANALYSIS RESULTS
The results of the total protein, antigenic protein con-
centration, and each specific NRL glove allergen are
summarized in Table 3.
1. The total amounts of protein of the surgery and
examination NRL gloves were 265 μgg and 95 μgg,
respectively.
2. The antigenic protein concentrations of the sur-
gery and examination NRL gloves were 24.9 μgg
and 1.0 μgg, respectively.
3. The total amounts of the four specific allergens
in the surgery and examination NRL gloves were 2.18
μgg and 0.45 μgg, respectively.
DISCUSSION
As in other western countries, in Japan the number of
LA patients increased rapidly from 1990 to 2000.24-29
In Japan, various preventative procedures were
quickly implemented, such as low-protein processing
of NRL products, developing NRL free products, and
creating LA guidelines, and as a result, the preva-
lence of LA has been decreasing.29 However preven-
tative procedures for HCWs with LA have not been
well-established.
We believe that it is important to identify the
source allergens by serologic and skin tests and to
examine the amount of protein allergens in NRL
Hev b 6.02 Is the Most Important Allergen in Health Care Workers
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products. The results will provide a better under-
standing of the features of LA in Japan and find the
most efficient diagnostic procedures for diagnosis of
LA in HCWs. It was previously reported that HCWs
with LA were sensitized to LA by contact with NRL
products, such as NRL gloves, or inhalation of air
borne NRL allergens.16-18 Although it was reported
that HCWs with LA were mainly sensitized by NRL
gloves, no report has examined whether Japanese
HCWs are sensitized to the main extracted allergens
in NRL gloves. In this study, we examined 20 HCWs
who had worked at the Fujita Health University Hos-
pital in the 1990s and used the same NRL glove
brands. Although they worked in different hospital
settings, they used the same brands of NRL gloves in
the hospital. Therefore, we considered that these
HCWs had been sensitized to the same allergens in
NRL gloves.
The purpose of this study was to investigate the
sensitized allergens of these patients. First, we per-
formed a SPT with NRL glove extract in 20 HCWs
who had clinical symptoms, such as itchiness and
erythema, due to wearing NRL gloves at the Fujita
Health University Hospital in the 1990s. From the re-
sults, we identified 14 cases as the LA group and six
cases as the non-LA group. We considered that the
symptoms associated with NRL gloves in the non-LA
group were irritations and dank.
Both the sensitivity and specificity of the SPT with
NRL extract in the LA group were 100%. These re-
sults were similar to previously published results.30
We also performed SPTs with recombinant allergens
in the LA group. The positive ratios of SPT scores to
NRL glove extract, rHev b 6.01, and rHev b 6.02 in
the LA group were 100%. There were significant cor-
relations between the severity stages and SPT scores
to NRL glove extract or rHev b 6.02 in the LA group
(Spearman’s rank correlation coefficient; r = 0.615;
P < 0.01 and r = 0.724; P < 0.01, respectively) (Fig. 2,
3). These results suggested that the SPT reflected
the clinical symptoms of LA and was a useful tool to
diagnose LA. These results also suggested that
among the LA allergens, rHev b 6.02 reflected LA
clinical symptoms better than NRL extract in the
SPT. Bernstein et al. performed a SPT with 7 native
proteins purified from nonammoniated latex (Hev b
1, 2, 3, 4, 6.01, 7.01, and 13) and rHev b 5 in HCWs.31
They reported positive ratios of Hev b 2, 5, 6.01, and
13 greater than 60%. Our positive ratio of rHev b 6.01
was consistent with their results. Sussman et al. also
reported that using a combination of recombinant la-
tex allergens Hev b 5, 6, and 7 could identify LA with
93% sensitivity and 100% specificity.32 They reported
that the results of SPTs using recombinant allergens
were comparable to the results of SPTs using NRL
extract.
It has been reported that the diagnostic sensitivity
of latex specific IgE is 23―83%.32 ImmunoCAPTM, the
EIA with fluorescent substrate (FEIA) from Pharma-
cia Diagnostics, uses a non-ammoniated latex aller-
gen preparation with at least 10 different protein com-
ponents. Because of the possibility of mistakes in
identifying the most responsible antigen, use of re-
combinant allergens may therefore be of great value.
Rihs H-P et al. reported the IgE-binding prevalence of
the allergens as follows, the prevalence of rHev b 1
for SB was 81%, while HCWs was 52%. The preva-
lence of rHev b 3 for SB was 76―78%, while HCWs
was 13―20%. The prevalence of rHev b 6.02 for HCWs
was 75%, while SB was 27%.33 Based on the these re-
sults, we considered that it was useful to measure re-
combinant allergens of LA in the specific IgE rather
than crude LA allergen.
We measured the serum specific IgE for latex and
recombinant latex allergens in the LA group (n = 14).
The positive ratios of serum specific IgE for latex,
rHev b 6.01, and 6.02 in the LA group were 100%,
while those of rHev b 5, rHev b 8, and rHev b 11 were
42.8%, 14.2%, and 7.1%, respectively. We considered
that Hev b 6.02 mainly contributed to LA sensitiza-
tion. Although five of the six cases in the non-LA
group showed positive reactions for latex specific
IgE, all cases showed negative reactions for rHev b
6.02 specific IgE. This suggested that false positive
reactions occurred with latex specific IgE when using
latex extract. In this study, the sensitivity of latex spe-
cific IgE was high but the specificity was low, while
both the sensitivity and the specificity of rHev b 6.02
specific IgE were high. Therefore, we concluded that
rHev b 6.02 specific IgE was more useful than latex
specific IgE for diagnosing LA.
When SPT was compared with specific IgE for di-
agnosis, we considered that SPT with latex allergen
was most relevant for diagnosis of LA in HCWs com-
pared to measurement in specific IgE. We have fur-
ther shown that the accuracy of the examinations
would increase by using the recombinant allergen,
especially rHev b 6.02, for HCWs with LA. Hamilton
et al. also reported that in vitro assays possess subop-
timal diagnostic sensitivity compared to SPTs in iden-
tifying HCWs with LA.34
We measured the total amount of proteins and al-
lergens in each NRL glove that had been used in our
hospital. The total amounts of proteins were 265 μgg
in the surgery glove and 95 μgg in the examination
glove. The antigenic protein concentrations were 24.9
μgg and 1.0 μgg in each respective glove. Our re-
sults of allergen levels with the gloves were low com-
pared with the NRL gloves used in Europe and the
US.23
Children with neural tube defects such as SB have
a particularly high prevalence of LA. Latex-sensitive
persons with SB reacted preferentially to Hev b 1 and
Hev b 3 proteins, whereas latex-sensitive HCWs are
more apt to be sensitized to Hev b 5 and Hev b 6.
Such differences are considered due to the different
Yagami A et al.
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amounts of major allergic proteins eluted from caus-
able products in patient groups. In our research, the
allergens of the NRL gloves were only Hev b 5 and
Hev b 6.02. We consider that those results have re-
flected the clinical conditions of HCWs. Yip et al.
have reported that the allergenicity of NRL products
can be estimated only by measuring the levels of four
allergens: Hev b 1, Hev b 3, Hev b 5, and Hev b
6.02.35 Koh et al. performed similar examinations in
Singapore HCWs and reported that NRL allergen lev-
els (Hev b 1, Hev b 3, Hev b 5, and Hev b 6.02) are
present in the majority of examination gloves at suffi-
ciently high levels to cause LA among sensitized per-
sons.36 They concluded that their research provides
evidence that could require manufacturers to pro-
duce gloves with low NRL allergen levels and to re-
port allergen levels in the glove product information.
Therefore, in this study we analyzed these four aller-
gens in NRL gloves. Yeang et al. suggested that Hev
b 5 and Hev b 13 played important roles in determin-
ing the allergenicity of NRL gloves.37 In this study,
we did not estimate the amount of Hev b 13 because
it was difficult to prepare native Hev b 13 with suffi-
cient purity. On the other hand, Palosuo et al. quanti-
fied four NRL allergens (Hev b 1, 3, 5, and 6.02) in all
medical glove brands marketed in Finland in 1999,
2001, and 2003 by a capture enzyme immunoassay.23
They concluded that when the sum of these four al-
lergens was 0.15 μgg, these gloves could be distin-
guished as ‘low allergenic’. In our examinations, the
sum of four allergens was 2.18 μgg in the surgery
glove and 0.45 μgg in the examination glove, sug-
gesting that these gloves had high allergenicity. Hev
b 5 and Hev b 6.02 were detected in the surgery
glove, and Hev b 6.02 was detected in the examina-
tion glove. The allergenicity results in the NRL gloves
were the same as the SPT results and specific IgE
analysis using recombinant latex allergens in HCWs.
Although, the ideal method for measuring the aller-
genicity of NRL products is to perform SPTs in LA pa-
tient volunteers, this test method is ethically impossi-
ble. Therefore, when purchasing NRL gloves, this al-
lergen measuring method will be useful. We de-
scribed the actual procedures for preventing sensiti-
zation in the HCWs previously.29 We have considered
that the most effective procedure was using powder-
free latex gloves in medical settings. Because powder
free gloves usually undergo low-proteinized proce-
dures in the manufacturing process, the risk of sensi-
tization to latex would be much smaller. Although re-
cent change from latex to latex free tools are often
found in many of the medical institutions, there are
still many that select latex-powdered gloves. If latex-
free gloves are employed exclusively in all medical
settings, there will be no chance of latex sensitization
a priori and further more, no symptoms will be in-
duced even in HCWs with LA, although this poses as
an economical burden for the hospital administration.
In order to address these points, HCWs with LA
should use latex-free gloves while others without LA
should use the powder free gloves. In Japan, the
guideline for LA was made in 2006.38 The guideline
includes many educational suggestions. It is very use-
ful for HCWs and hospital managers. However, be-
cause of the limitation due to data derived from only
retrospective studies, Bousquet et al. reported that
the effect of these interventions could not be as-
sessed with powder-free NRL gloves.39 The effect of
powder-free gloves was examined only in one pro-
spective cohort study, which failed to show a protec-
tive effect of powder-free NRL gloves for LA. Further
studies are needed to investigate this point. In this
study, we characterized the most important allergen
in HCWs sensitized occupationally by NRL gloves.
We concluded that the main allergen in HCWs sensi-
tized occupationally by NRL gloves was Hev b 6.02.
More measurements for LA are needed in hospital
settings. In addition, hospitals will have to continue to
be cautious about latex exposure and be particularly
mindful of the amounts of Hev b 5 or Hev b 6.02 in la-
tex gloves.
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